Biological effects of secretory phospholipase A2 group IIA on lipoproteins and in atherogenesis
Authors:
- 13 June 2002
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 32 (6) , 383-393
Abstract
Secretory phospholipase A2 group IIA(sPLA2 IIA) can be produced and secreted by various cell types either constitutionally or as an acute‐phase reactant upon stimulation by proinflammatory cytokines. The enzyme prefers phosphatidylethanolamine and phosphatidylserine as substrates. One important biological function may be the hydrolytic destruction of bacterial membranes. It has been demonstrated, however, that sPLA2 can also hydrolyse the phospholipid monolayers of high density lipoprotein (HDL) and low density lipoprotein (LDL) in vitro. Secretory phospholipase A2‐modified LDL show increased affinity to glycosaminoglycans and proteoglycans, a tendency to aggregate, and an enhanced ability to deliver cholesterol to cells. Incubation of cultured macrophages with PLA2‐treated LDL and HDL is associated with increased intracellular lipid accumulation, resulting in the formation of foam cells. Elevated sPLA2(IIA) activity in blood serum leads to an increased clearance of serum cholesterol. Secretory phospholipase A2(IIA) can also be detected in the intima, adventitia and media of the atherosclerotic wall not only in developed lesions but also in very early stages of atherosclerosis. The presence of DNA of Chlamydia pneumoniae, herpes simplex virus, and cytomegalovirus was found to be associated with sPLA2(IIA) expression and other signs of local inflammation. Thus, sPLA2(IIA) appears to be one important link between the lipid and the inflammation hypothesis of atherosclerosis.Keywords
This publication has 137 references indexed in Scilit:
- Alterations in the physicochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label studyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Cloning, expression and partial characterization of a novel rat phospholipase A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Purification and characterization of a phospholipase A2 from human ileal mucosaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Cloning of the cDNA coding for 14 kDa group II phospholipase A2 from rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Behaviour of phospholipase modified-HDL towards cultured hepatocytes. II. Increased cell cholesterol storage and bile acid synthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Behaviour of phospholipase-modified HDL towards cultured hepatocytes. I. Enhanced transfers of HDL sterols and apoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Immunochemical detection of ‘ platelet type’ phospholipase A2 in the ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Transfer of free and esterified cholesterol from low-density lipoproteins and high-density lipoproteins to human adipocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Uptake of HDL unesterified and esterified cholesterol by human endothelial cells. Modulation by HDL phospholipolysis and cell cholesterol contentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986